...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability
【24h】

NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability

机译:来自聚(D,L-丙交酯 - 共乙酰基)微球的NGF释放。 一些配方参数对封装NGF稳定性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Poly(D,L-lactide-co-glycolide) (PLGA 37.5/25 and 25/50) biodegradable microparticles, which allow the locally delivery of a precise amount of a drug by stereotactic injection in the brain, were prepared by a W/O/W emulsion solvent evaporation/extraction method which had been previously optimized. The aim of this work was to study the influence of two formulation parameters (the presence of NaCl in the dispersing phase and the type of PLGA) on the NGF release profiles and NGF stability during microencapsulation. A honey-comb-like structure characterized the internal morphology of the microspheres. The initial burst was attributed to the rapid penetration of the release medium inside the matrix through a network of pores and to the desorption of weakly adsorbed protein from the surface of the internal cavities. The non-release fraction of the encapsulated protein observed after twelve weeks of incubation was accounted for firstly by the adsorption of the released protein on the degrading microparticles and secondly by the entanglement of the encapsulated protein in the polymer chains. The use of sodium chloride in the dispersing phase of the double emulsion markedly reduced the burst effect by making the microparticle morphology more compact. Unfortunately, it induced in parallel a pronounced NGF denaturation. Finally, it appeared that microparticles made from a hydrophilic uncapped PLGA 37.5/25 in the absence of salt, allowed the release of intact NGF at least during the first 24 h as determined by both ELISA and a PC12 cell-based bioassay. (C) 1998 Elsevier Science B.V. All rights reserved. [References: 24]
机译:通过W /通过脑内注射允许通过立体定向注射允许通过立体定向注射局部递送局部递送的可生物降解的微粒(D,L-丙交酯 - 共乙酰胺)(PLGA 37.5 / 25和25/50)可生物降解的微粒。 O / W乳液溶剂蒸发/提取方法,其先前优化。这项工作的目的是研究两种配方参数的影响(在分散相中的NaCl的存在和PLGA的类型)在微胶囊期间NGF释放谱和NGF稳定性。蜂蜜梳状结构表征了微球的内部形态。初始突发归因于通过孔网络和从内腔表面的弱吸附蛋白质的解吸来归因于释放介质的快速渗透。在孵育12周后观察到的包封蛋白的非释放分数首先通过在降解微粒上吸附释放的蛋白质,其次通过聚合物链中包封蛋白的缠结。使用氯化钠在双乳液的分散阶段中通过使微粒形态更紧凑地显着降低了突发效果。不幸的是,它在并行诱导明显的NGF变性。最后,似乎在没有盐的情况下,由亲水未缩合的PLGA 37.5 / 25制成的微粒,其允许至少在由ELISA和PC12细胞基生物测定中确定的前24小时期间释放完整的NGF。 (c)1998年Elsevier Science B.v.保留所有权利。 [参考:24]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号